Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Promising evidence emerges about the efficacy of the first reversal agent for one of the non-vitamin K oral anticoagulants.</p>

Study: Idarucizumab Safely Reverses Anticoagulant Effect of Dabigatran